Advertisement

Topics

Cannabinoid Agonist Pipeline Insight, 2018 – ResearchAndMarkets.com

10:04 EST 20 Feb 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Cannabinoid Agonist -Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. ‘Cannabinoid Agonist – Pipeline Insight, 2018’ report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Cannabinoid Agonist development. The … Continue reading

Cet article Cannabinoid Agonist Pipeline Insight, 2018 – ResearchAndMarkets.com est apparu en premier sur Biotech 365.

Original Article: Cannabinoid Agonist Pipeline Insight, 2018 – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Cannabinoid Agonist Pipeline Insight, 2018 – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...